PT1051398E - Forma termodinamicamente estevel de acido (r)-3-¬¬(4-fluorofenil) sulfonil|amino| -1,2,3,4-tetrehidro-9h-carvazol-9-propanoico (ramatroban) - Google Patents

Forma termodinamicamente estevel de acido (r)-3-¬¬(4-fluorofenil) sulfonil|amino| -1,2,3,4-tetrehidro-9h-carvazol-9-propanoico (ramatroban)

Info

Publication number
PT1051398E
PT1051398E PT98961506T PT98961506T PT1051398E PT 1051398 E PT1051398 E PT 1051398E PT 98961506 T PT98961506 T PT 98961506T PT 98961506 T PT98961506 T PT 98961506T PT 1051398 E PT1051398 E PT 1051398E
Authority
PT
Portugal
Prior art keywords
carboxol
tetrehydro
ramatroban
thermodynamically
propanoic
Prior art date
Application number
PT98961506T
Other languages
English (en)
Portuguese (pt)
Inventor
Karl-Heinz Wahl
Alfons Grunenberg
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of PT1051398E publication Critical patent/PT1051398E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT98961506T 1997-12-24 1998-12-24 Forma termodinamicamente estevel de acido (r)-3-¬¬(4-fluorofenil) sulfonil|amino| -1,2,3,4-tetrehidro-9h-carvazol-9-propanoico (ramatroban) PT1051398E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)

Publications (1)

Publication Number Publication Date
PT1051398E true PT1051398E (pt) 2004-07-30

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98961506T PT1051398E (pt) 1997-12-24 1998-12-24 Forma termodinamicamente estevel de acido (r)-3-¬¬(4-fluorofenil) sulfonil|amino| -1,2,3,4-tetrehidro-9h-carvazol-9-propanoico (ramatroban)

Country Status (36)

Country Link
US (1) US6362214B1 (enExample)
EP (1) EP1051398B1 (enExample)
JP (2) JP3817668B2 (enExample)
KR (1) KR100586350B1 (enExample)
CN (1) CN1140510C (enExample)
AR (1) AR013803A1 (enExample)
AT (1) ATE263152T1 (enExample)
AU (1) AU744242B2 (enExample)
BG (1) BG65024B1 (enExample)
BR (1) BR9814496A (enExample)
CA (1) CA2313230A1 (enExample)
CO (1) CO4970800A1 (enExample)
DE (2) DE19757983A1 (enExample)
DK (1) DK1051398T3 (enExample)
ES (1) ES2218874T3 (enExample)
GT (1) GT199800198A (enExample)
HN (1) HN1998000186A (enExample)
HU (1) HUP0004432A3 (enExample)
ID (1) ID25446A (enExample)
IL (1) IL136278A (enExample)
IN (1) IN192932B (enExample)
MY (1) MY116312A (enExample)
NO (1) NO316618B1 (enExample)
NZ (1) NZ504741A (enExample)
PE (1) PE20000115A1 (enExample)
PL (1) PL341359A1 (enExample)
PT (1) PT1051398E (enExample)
RU (1) RU2220137C2 (enExample)
SI (1) SI1051398T1 (enExample)
SK (1) SK285109B6 (enExample)
TR (1) TR200001936T2 (enExample)
TW (1) TW552258B (enExample)
UA (1) UA66832C2 (enExample)
UY (2) UY25324A1 (enExample)
WO (1) WO1999033803A1 (enExample)
ZA (1) ZA9811817B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008075028A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2008087371A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
ES2991300T3 (es) 2015-02-13 2024-12-03 Inserm Institut Nat De La Sante Et De Larecherche Medicale Antagonistas de PTGDR-1 y/o PTGDR-2 para prevenir y/o tratar lupus eritematoso sistémico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
IL136278A0 (en) 2001-05-20
ES2218874T3 (es) 2004-11-16
TR200001936T2 (tr) 2001-01-22
JP4411269B2 (ja) 2010-02-10
HUP0004432A3 (en) 2002-10-28
US6362214B1 (en) 2002-03-26
NO316618B1 (no) 2004-03-08
CN1282320A (zh) 2001-01-31
DE69822882D1 (en) 2004-05-06
TW552258B (en) 2003-09-11
WO1999033803A1 (en) 1999-07-08
ZA9811817B (en) 1999-06-29
ID25446A (id) 2000-10-05
CA2313230A1 (en) 1999-07-08
AR013803A1 (es) 2001-01-10
RU2220137C2 (ru) 2003-12-27
BG104554A (en) 2001-05-31
NZ504741A (en) 2002-10-25
SK9752000A3 (en) 2001-02-12
EP1051398A1 (en) 2000-11-15
DK1051398T3 (da) 2004-07-19
IN192932B (enExample) 2004-06-12
DE69822882T2 (de) 2005-02-03
SI1051398T1 (en) 2004-08-31
KR20010033529A (ko) 2001-04-25
CO4970800A1 (es) 2000-11-07
AU744242B2 (en) 2002-02-21
ATE263152T1 (de) 2004-04-15
JP3817668B2 (ja) 2006-09-06
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
BR9814496A (pt) 2000-10-10
NO20003217L (no) 2000-06-21
AU1687499A (en) 1999-07-19
HUP0004432A2 (hu) 2001-06-28
CN1140510C (zh) 2004-03-03
IL136278A (en) 2005-03-20
HN1998000186A (es) 1999-11-03
PE20000115A1 (es) 2000-03-26
HK1034517A1 (en) 2001-10-26
UY25324A1 (es) 2000-12-29
EP1051398B1 (en) 2004-03-31
GT199800198A (es) 1998-12-15
UA66832C2 (uk) 2004-06-15
JP2006151977A (ja) 2006-06-15
BG65024B1 (bg) 2006-12-29
DE19757983A1 (de) 1999-07-01
PL341359A1 (en) 2001-04-09
JP2001527067A (ja) 2001-12-25
NO20003217D0 (no) 2000-06-21
UY25575A1 (es) 1999-11-17
MY116312A (en) 2003-12-31

Similar Documents

Publication Publication Date Title
IT1298227B1 (it) Procedimento per la produzione di anidride ftalica
BR9808037B1 (pt) mistura de sàlidos, e, processo para a preparaÇço de formulaÇÕes herbicidas.
IT1283232B1 (it) Procedimento per la sintesi di 2-buten-1, 4-diesteri
AR016694A1 (es) Procedimiento para la preparacion de derivados de acidos 8-metoxi-3-quinoloncarboxilicos y procedimiento de purificacion.
PT1051398E (pt) Forma termodinamicamente estevel de acido (r)-3-¬¬(4-fluorofenil) sulfonil|amino| -1,2,3,4-tetrehidro-9h-carvazol-9-propanoico (ramatroban)
FR2832587B1 (fr) Systeme de reperage et d'adressage des feux d'un reseau de balisage
IT1303759B1 (it) Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
IT1274571B (it) Procedimento per la preparazione di ¬r-(r*,r*)|-5-(3-clorofenil)-3- ¬2-(3,4-dimetossifenil)-1-metil-etil|-ossazolidin-2-one
ITMI981833A0 (it) Processo per la preparazione di zofenopril sale di calcio
ID25536A (id) Metode pembuatan asam-asam 4-fenil-4-sianosikloheksanoat tersubstitusi
ZA975755B (en) Useful formulations of acid addition salt drugs.
PT1133495E (pt) Semi-hidrocloreto do acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|-nonano-8-il)-6-fluoro-1,4-diidro-4-oxo-3-quinolinocarboxilico
DE59802620D1 (de) Verfahren zur Herstellung von trans-(R,R)-Actinol
IT1313660B1 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
NO981499D0 (no) Fremgangsmåte for fremstilling av titandioksyd
AU8985298A (en) Novel sulphonamide derived from substituted anilines useful as medicines
IT1283642B1 (it) Procedimento per la preparazione di acido poliaspartico
IT1292007B1 (it) Processo per la preparazione di hcfc-123
IT1291675B1 (it) Procedimento per la preparazione dell'acido 4,5-difenilossazol-2- propanoico
DE59813193D1 (de) Verfahren zur Herstellung von Sulfonylharnstoffsalzen
ITRM970049A0 (it) Procedimento per la preparazione dell'acido 2-iodossibenzoico.
IT1298240B1 (it) Procedimento per la preparazione dell'acido 4,4'-diamminostilben- 2,2'-disolfonico
ITMI970682A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4- tetraidroisochinolin-3- carbossiammide
IT1292409B1 (it) Procedimento per la preparazione di oxatomide
IT1276915B1 (it) Procedimento per la preparazione dell'acido 7-(d-2-idrossi-2- fenilacetammido)-3-(1-sulfometil-1-h-tetrazol-5-il)-tiometil-3-